Molecular docking of active compounds from traditional medicinal plants as ACE-2 protein (1R4L) inhibitor in searching for COVID-19 drug

Tungary, Emilia and Ongko, Jeremi and Sukweenadhi, Johan and Antonius, Yulanda (2022) Molecular docking of active compounds from traditional medicinal plants as ACE-2 protein (1R4L) inhibitor in searching for COVID-19 drug. Research Journal of Pharmacy and Technology, 15 (9). pp. 4235-4240. ISSN 0974-3618 (Print); 0974-360X (Online)

[thumbnail of Yulanda_Molecular Docking of Active Compounds.pdf] PDF
Yulanda_Molecular Docking of Active Compounds.pdf

Download (1MB)
Official URL / DOI: https://rjptonline.org/AbstractView.aspx?PID=2022-...

Abstract

Coronavirus disease known as COVID-19 is a global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 binds to the receptor binding-domain of ACE-2. By blocking it with a specific ligand, we can prevent SARS-CoV-2 binding and therefore prevent its cellular entry and injury. The number of COVID-19 cases is still increasing and yet only 2.5% of Indonesians are fully vaccinated. Moreover, up to now, a specific cure for COVID-19 has not been found yet. However, many traditional medicinal plants have the potency of becoming COVID-19 drugs. Therefore, this study aimed to examine various active compounds derivate from the traditional medicinal plant as an inhibitor of SARS-CoV-2 receptor in human cell termed as ACE2. The activity and drug-likeness of the active compounds were predicted and molecular docking were conducted to identify the interactions between ligands and ACE-2. Toxicity assay was also identified to predict the toxicity class, lethal dose, and organ toxicity. This study showed that indirubin has lower binding energy as compared to the sulabiroins A and MLN-4760 as comparative control and potent inhibitor control, respectively. Indirubin shared similar interaction with amino acid residue to ACE-2 as compared to control. Based on the research result, it was suggested that Indirubin could be developed as a promising compound for COVID-19 antiviral drugs. KEYWORDS: ACE-2 inhibitor, Antiviral drug, Coronavirus, Indirubin, Sulabiroins A.

Item Type: Article
Uncontrolled Keywords: ACE-2 inhibitor, Antiviral drug, Coronavirus, Indirubin, Sulabiroins A
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Technobiology > Department of Biology
Depositing User: YULANDA ANTONIUS
Date Deposited: 24 Oct 2022 02:43
Last Modified: 24 Oct 2022 04:11
URI: http://repository.ubaya.ac.id/id/eprint/42784

Actions (login required)

View Item View Item